말초 삽입형 중심정맥 카테터 시장 : 제품별, 루멘별, 용도별, 최종 용도별, 예측(2024-2032년)

Peripherally inserted central catheters market size is set to register 9.6% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, which require prolonged administration of medications and fluids. As per WHO, in 2022, approximately 20 million new cancer cases were reported, resulting in 9.7 million mortalities. Peripherally inserted central catheters (PICCs) offer a reliable and less invasive alternative to traditional central venous catheters for providing patients with extended vascular access for weeks to months. This has led to their widespread adoption in hospitals and outpatient settings, where they facilitate the delivery of chemotherapy, parenteral nutrition, and antibiotics, among other therapies.

Innovations, such as antimicrobial coatings and radiopaque materials for accurate placement, and integrated flushing systems are improving infection control, visibility under imaging, and overall catheter management. The shift towards minimally invasive procedures and outpatient care models is also supporting the adoption of PICCs as they offer reduced complication rates and shorter hospital stays compared to traditional central lines.

The peripherally inserted central catheters industry is divided into product, lumen, application, end-use and region.

Based on product, the market size from the conventional PICC segment is poised to generate substantial revenue during 2024-2032 due to its established track record of safety, reliability, and familiarity among healthcare providers. Conventional PICCs are widely used in clinical settings for their versatility in delivering long-term intravenous therapies while minimizing the risks associated with more invasive central venous catheters. These devices are also equipped with features that facilitate precise placement, ease of maintenance, and compatibility with a wide range of medications and treatments.

Concerning end-use, the PICC market from the home-care settings segment is set to witness decent growth over the forecast period. This is backed by the strong need for offering patients a convenient and cost-effective option for receiving long-term intravenous therapy outside of traditional hospital settings. PICCs also provide a reliable method for administering medications, fluids, and parenteral nutrition directly into a central vein, thereby supporting patients with chronic conditions who require prolonged treatment at home.

Asia Pacific peripherally inserted central catheters industry size will surge significantly through 2032. Advancements in healthcare infrastructure and rising healthcare expenditure in the region are supporting the adoption of PICCs in hospitals and outpatient settings, where they facilitate the administration of chemotherapy, antibiotics, and parenteral nutrition. The growing elderly population in APAC countries, coupled with shifting healthcare policies that prioritize patient comfort and cost-efficiency, will further contribute to the market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of infectious diseases
    • 3.2.1.2 Rising prevalence of chronic conditions:
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Increasing healthcare expenditure and preference for PICCs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High risk of catheter-related bloodstream infections (CRBSI)
    • 3.2.2.2 Malfunctioning of the device
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technological landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Power injected PICC
• 5.3 Conventional PICC
• 5.4 Neonatal PICC

Chapter 6 Market Estimates and Forecast, By Lumen, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Single
• 6.3 Double
• 6.4 Multiple

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Chemotherapy
• 7.3 Long-term IV infusion
• 7.4 Parenteral nutrition
• 7.5 Blood transfusion
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Homecare settings
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Access Vascular, Inc.
• 10.2 AngioDynamic, Inc.
• 10.3 Argon Medical
• 10.4 B. Braun Medical Ltd
• 10.5 Becton, Dickinson and Company
• 10.6 Biowy Corporation
• 10.7 Cardinal Health, Inc.
• 10.8 Footprint Medical Incorporated
• 10.9 ICU Medical, Inc.
• 10.10 Kimal Plc
• 10.11 Medi-Tech Devices
• 10.12 Teleflex Incorporated